Olaratumab Plus Trabectedin in Advanced Soft-tissue Sarcoma Patients Soft-tissue Sarcoma Patients
Condition(s):Sarcoma, Soft TissueLast Updated:March 27, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Sarcoma, Soft TissueLast Updated:March 27, 2023Active, not recruiting
Condition(s):LeiomyosarcomaLast Updated:March 18, 2019Withdrawn
Condition(s):Soft Tissue SarcomaLast Updated:April 13, 2023Completed
Condition(s):Soft Tissue SarcomaLast Updated:September 10, 2020Completed
Condition(s):Soft Tissue SarcomaLast Updated:August 12, 2019Completed
Condition(s):NeoplasmLast Updated:February 17, 2021Completed
Condition(s):Sarcoma, Soft TissueLast Updated:November 21, 2019Completed
Condition(s):Soft Tissue SarcomaLast Updated:May 9, 2022Completed
Condition(s):Malignancy; MetastasisLast Updated:April 14, 2017Completed
Condition(s):Neoplasm MetastasisLast Updated:May 20, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.